Immunic, inc. to participate in the piper sandler & co. 33rd annual virtual healthcare conference

New york, nov. 23, 2021 /prnewswire/ -- immunic, inc. (nasdaq: imux), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, today announced that daniel vitt, ph.d., chief executive officer and president, will participate in a fireside chat at the piper sandler & co. 33rd annual virtual healthcare conference, taking place november 29-december 2, 2021.
IMUX Ratings Summary
IMUX Quant Ranking